Total value in 2019: $14,114.25M (351 completed)

Company Location Gross (US$M) Round

October - $1,517.22M

Abalos Therapeutics GmbH Essen, Germany $13.20 Series A
Adaptive Phage Therapeutics Inc. Gaithersburg, Md. $7.00 N/A
Adicet Bio Inc. Menlo Park, Calif. $80.00 Series B
Aeovian Pharmaceuticals San Francisco $37.00 Series A
Allievex Corp. Marblehead, Mass. N/A Series A
Amacathera Inc. Toronto $3.60 Seed
Amarna Therapeutics BV Leiden, the Netherlands $11.00 Seed
Arcellx Inc. Gaithersburg, Md. $85.70 Series B
Arcutis Biotherapeutics Inc. Westlake Village, Calif. $94.50 Series C
Arrevus Inc. Raleigh, N.C. N/A Loan
Arsenal Biosciences Inc. South San Francisco $85.00 Series A
Azitra Inc. Farmington, Conn. $14.00 Series A
Aztherapies Inc. Boston $26.30 Series C
Biorchestra Co. Ltd. Daejeon, Korea $4.10 Series B
Bryn Pharma LLC Raleigh, N.C. $17.50 N/A
Cygnal Therapeutics Inc. Cambridge, Mass. $65.00 Seed
Cyteir Therapeutics Inc. Lexington, Mass. $40.20 Series B
Disc Medicine Inc. Cambridge, Mass. $50.00 Series A
Elicio Therapeutics Inc. Cambridge, Mass. $33.00 Series B
Forbius Inc. Austin, Texas N/A Series C
Genome & Co. Ltd. Seongnam, South Korea $25.20 Series C
Healx Ltd. Cambridge, U.K. $56.00 Series B
Icosavax Inc. Seattle $51.00 Series A
Immunomolecular Therapeutics LLC Aurora, Colo. $10.00 Series A
Intrepida Bio Inc. San Diego $9.50 Seed
Kira Biotech Pty Ltd. Brisbane, Australia $13.72 Series A
Kobiolabs Inc. Seoul, South Korea $22.20 N/A
Korro Bio Inc. Cambridge, Mass. $4.00 Seed
Lygenesis Inc. Pittsburgh $4.00 N/A
Maverix Oncology Inc. Palo Alto $20.00 Series A
Mirobio Ltd. Oxford $33.30 Series A
Mogrify Ltd. Cambridge, U.K. $16.00 Series A
Neurorx Inc. Wilmington, Del. $95.60 N/A
Nevakar Inc. Bridgewater, N.J. $17.50 N/A
Nuvation Bio Inc. New York $275.00 Series A
Pepticom Ltd. Jerusalem $5.00 Series A
Plexium Inc. San Diego $28.00 Series A
Prokarium Ltd. London $5.60 Seed
Rznomics Inc. Gwangju, South Korea $10.00 Series A
Systems Oncology LLC Scottsdale, Ariz. N/A Series B
Tenaya Therapeutics Inc. South San Francisco $92.00 Series B
Turn Therapeutics Inc. Los Angeles N/A Series B
Versameb AG Basel, Switzerland $6.50 Series C
Verseau Therapeutics Inc. Bedford, Mass. $50.00 Seed
Viracta Therapeutics Inc. San Diego N/A Series D

No Comments